Tennis-World No 1 Sinner cleared of wrongdoing after failed drug tests, ITIA says
Adds details, statements from Sinner and ATP
Aug 20 (Reuters) -World men's number one Jannik Sinner has been cleared of fault or negligence by an independent tribunal after failing two drug tests in March, the International Tennis Integrity Authority (ITIA) said on Tuesday.
The tribunal accepted Sinner's explanation that the anabolic agent clostebol entered his system from a member of his support team through massages and sports therapy, the ITIA said in a statement.
The team member had been applying an over-the-counter spray containing clostebol to their own skin to treat a small wound, the ITIA added.
"After each positive test, a provisional suspension was applied. On both occasions, Sinner successfully appealed the provisional suspension and so has been able to continue playing," the statement said.
The decision is subject to appeal by the World Anti-Doping Agency (WADA) and the Italian Anti-Doping Agency (NADO Italia), the statement added.
Sinner, who won the Cincinnati Open on Monday, said the independent tribunal had cleared him in April after he fully cooperated in the ITIA's investigation.
"I will now put this challenging and deeply unfortunate period behind me," he said in a statement, adding that the amount of clostebol found in his system was less than a billionth of a gram.
"I will continue to do everything I can to ensure I continue to comply with the ITIA's anti-doping programme and I have a team around me that are meticulous in their own compliance," he added.
The ATP said they were encouraged by the ruling.
"This has been a challenging matter for Jannik and his team, and underscores the need for players and their entourages to take utmost care in the use of products or treatments. Integrity is paramount in our sport," they said in a statement.
Australian Open champion Sinner will play in the U.S. Open later this month, with the main draw starting on Aug. 26.
Reporting by Chiranjit Ojha in Bengaluru; Editing by Hugh Lawson
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
